Health officials have cleared a novel non-hormonal medication designed to alleviate menopausal hot flushes. The treatment operates by modulating the body’s temperature regulation mechanisms and has become accessible through the NHS in England for patients unable to tolerate hormone replacement therapy.
The program explores this development with resident GP Dr Margaret McCartney, examining both the clinical evidence supporting the drug and the patient experience of hot flushes. The discussion addresses why this new therapeutic option represents an important addition to the available treatments for menopause-related symptoms.
Separately, Dr Manjula Meda, a microbiologist, is leading a research initiative focused on hospital water systems as potential sources of antimicrobial resistance. Her approach involves eliminating sinks from hospital wards to interrupt transmission pathways. The investigation examines whether this intervention proves both effective and safe in clinical settings.
Additionally, the program features Professor Brantley Hall from the University of Maryland, who has developed technology to detect and measure intestinal gas emissions. This device provides researchers with quantifiable data to better understand digestive health. The presenter participates in a three-day trial of the detection apparatus to demonstrate its application in research contexts.
The broadcast was produced by the BBC’s Audio Science Unit in partnership with The Open University.